13-cis Retinoic Acid Inhibits Development and Progression of Chronic Allograft Nephropathy
Am J Pathol Adams et al.
167: 285
Supplemental Material for Am J Pathol 2005, 167:285-298 (Adams et al)
Files in this Data Supplement:
Supplemental Tables and Figures
-
Supplemental Tables A, B: Effects of 13cRA on graft rejection; Supplemental Figures A-E: Treatment with 13cRA for 56 days significantly reduced the morphological signs of acute rejection phenomena (A-C) and chronic damage (D, E) when compared to placebo-56 days and placebo-14 days groups. The values for the placebo-14 days group which have already been depicted in reference 17 have been added to facilitate interpretation of the data set. (MSWord document, 74 KB)
